A detailed history of Blue Crest Capital Management LTD transactions in Pfizer Inc stock. As of the latest transaction made, Blue Crest Capital Management LTD holds 87,036 shares of PFE stock, worth $2.44 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
87,036
Previous 520,897 83.29%
Holding current value
$2.44 Million
Previous $15 Million 83.9%
% of portfolio
0.13%
Previous 0.63%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $11.2 Million - $12.9 Million
-433,861 Reduced 83.29%
87,036 $2.42 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $11.6 Million - $15 Million
442,039 Added 560.55%
520,897 $15 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $1.99 Million - $2.32 Million
61,909 Added 365.27%
78,858 $2.62 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $612,197 - $708,298
16,949 New
16,949 $621,000
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $656,951 - $745,556
-19,956 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $422,077 - $547,310
12,991 Added 186.52%
19,956 $717,000
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $9.81 Million - $11 Million
-265,353 Reduced 97.44%
6,965 $302,000
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $4.77 Million - $5.24 Million
127,261 Added 87.73%
272,318 $11.6 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $5.58 Million - $6.36 Million
145,057 New
145,057 $6.33 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $15 Million - $18.2 Million
-435,609 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $14.4 Million - $15.3 Million
435,609 New
435,609 $15.8 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $223,593 - $259,399
-7,007 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $233,052 - $247,277
7,007
7,007 $254,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Blue Crest Capital Management LTD Portfolio

Follow Blue Crest Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Blue Crest Capital Management LTD with notifications on news.